Patient Controlled Injectors Market Size & Growth | Report 2027

Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Electronic Wearable Injectors, Mechanical Wearable Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies), and Geography

  • Report Code : TIPRE00015234
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 175
Buy Now

The patient controlled market was valued at US$ 2,969.47 million in 2019 and is projected to reach US$  7,505.70 million by 2027; it is expected to grow at a CAGR of 12.4% from 2020 to 2027.

The patient controlled injectors are the recent invention in the administration of injections. There are high-unmet needs of people/ HCPs or patients’ requiring the patient-controlled injectors, as it has greater ease and comfort than any other auto-injectors. These are ergonomically developed, and the design of patient-controlled injectors can help optimize self-care, making it easy for patients to handle the system and administer the dosages at just one press. The patient controlled injectors market is expected to witness a significant growth due to increasing prevalence of infectious diseases and growing emphasis on superior patient compliance. However, poor adoption of injectors in emerging countries is likely to deter the growth of the market during the forecast period.

Lucrative Regions for Patient Controlled Injectors Market



Lucrative Regions for Patient Controlled Injectors Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Rising Prevalence of Chronic Diseases

Patient controlled Injectors are subcutaneous drug delivery systems that adhere to the body and administer larger volumes (more than 2 mL) of a drug over an extended period. With the use of patient-controlled injectors, dosing errors, microbial contamination risks, and needle stick injuries can be avoided that are caused during parenteral drug administration using injections. In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of various chronic diseases. However, the majority of the available treatment options require parenteral drug administration, frequent dosing, and repeated hospital visits. Therefore, patient controlled injectors are preferred for the treatment of chronic diseases where long-term treatment is necessary. Chronic diseases, such as blood disorder, autoimmune disorders, and various types of cancer, are the leading causes of death and disability worldwide. According to the Centers for Disease Control and Prevention, in 2019, nearly 6 in 10 people suffer from at least one chronic disease in the US.

Cardiovascular diseases (CVDs) are a significant cause of mortality globally owing to the hectic lifestyle. As per the World Health Organization (WHO), CVDs are the number one cause of death globally, taking an estimated 17.9 million lives each year. Many biologics are commercially available for the treatment, but the conventional drug delivery methods are unable to provide accurate dosage. This augments the use of patient controlled injector drug delivery systems that provide targeted drug delivery and prolonged drug residence to the affected areas of the cardiovascular system. Hence, the adoption of patient controlled injectors is likely to increase, thereby propelling the market growth.

Product-Based Insights

Based on product, the patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable injector segment held the largest share of the market; whereas, the mechanical wearable injector segment is likely to witness the fastest growth during the forecast period.

Global Patient Controlled Injectors Market, by Product – 2019 & 2027



Global Patient Controlled Injectors Market, by Product – 2019 & 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Application-Based Insights

Based on application, the patient controlled injectors market is segmented into cancer treatment, auto-immune treatment, blood disorders treatment, and others. The cancer treatment segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Distribution Channel-Based Insights

Based on distribution channel, the patient controlled injectors market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. The hospital pharmacies segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

The demand for patient controlled injectors increased during the pandemic. Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which, in turn caused a negative impact on the market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Patient Controlled Injectors Market: Strategic Insights

patient-controlled-injectors-market
Market Size Value inUS$ 2,969.47 Million in 2019
Market Size Value byUS$ 7,505.70 Million by 2027
Growth rateCAGR of 12.4% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and expansion strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the patient controlled injectors market adopted the strategy of product innovation to cater the changing customer demand across the world, which also permits the players to maintain their brand name globally.

Patient Controlled Injectors Market – By Product

  • Electronic Wearable Injector
  • Mechanical Wearable Injector
  • Infusion Pumps


Patient Controlled Injectors Market – By Application

  • Cancer Treatment
  • Auto-immune Treatment
  • Blood Disorders Treatment
  • Others


Patient Controlled Injectors Market – By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies


Patient Controlled Injectors Market– By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South & Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Gerresheimer AG
  • F. Hoffmann-La Roche Ltd.
  • Johnson and Johnson Services, Inc.
  • Ypsomed AG
  • Westbourne Medical Limited
  • Enable Injections
  • scPharmaceuticals Inc.
  • United Therapeutics Corporation
  • BD
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product ; Application ; Distribution Channel , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are patient controlled injectors market?

The patient-controlled injectors are the newest invention in the administration of injections. There are high-unmet needs of people/ HCPs or patients requiring the patient-controlled injectors as it has greater ease and comfort than any other auto-injectors. These are ergonomically developed, and design patient-controlled injectors can help optimize self-care, making it easy for patients to hold the system and administer the dosages at just one press.

What are the driving factors for the patient controlled injectors market across the globe?

The growth of the market is attributed to the increasing prevalence of chronic diseases and growing patient compliance.

Who are the major players in the patient controlled injectors market?

Gerresheimer AG, F. HOFFMANN-LA ROCHE LTD., Johnson and Johnson Services, Inc., Ypsomed AG, Westbourne Medical Limited, Enable Injections, scPharmaceuticals Inc., United Therapeutics Corporation and BD are some of the major players in the patient controlled injectors market.

The List of Companies - Patient Controlled Injectors Market

  1. West Pharmaceutical Services, Inc. 
  2. Gerresheimer AG
  3. F. HOFFMANN-LA ROCHE LTD.
  4. Johnson and Johnson Services, Inc.
  5. Ypsomed AG
  6. Westbourne Medical Limited
  7. Enable Injections
  8. scPharmaceuticals Inc.
  9. United Therapeutics Corporation
  10. BD

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Patient Controlled Injectors Market